Clinical Trial Update: A Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node Dissection [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Lymphoseek-identified sentinel lymph nodes to non-sentinel nodes in nodal staging for cervical cancer; the study was terminated and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Lymphoseek (tilmanocept)

Snippet

Sponsor: Cardinal Health 414, LLC | Conditions: Uterine Cervical Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2019-02-11